Literature DB >> 16897723

3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.

David A Karanian1, Andrea S Baude, Queenie B Brown, Christopher G Parsons, Ben A Bahr.   

Abstract

The over-activation of glutamate receptors can lead to excitotoxic cell death and is believed to be involved in the progression of neurodegenerative events in the vulnerable hippocampus. Here, we used an in vitro slice model to study toxicity produced in the hippocampus by the mitochondrial toxin 3-nitropropionic acid (3-NP). The organotypic slice cultures exhibit native cellular organization as well as dense arborization of neuronal processes and synaptic contacts. The hippocampal slices were exposed to 3-NP for 2-20 days, causing calpain-mediated breakdown of the spectrin cytoskeleton, a loss of pre- and postsynaptic markers, and neuronal atrophy. The N-methyl-D-aspartate (NMDA) receptor antagonist memantine reduced both the cytoskeletal damage and synaptic decline in a dose-dependent manner. 3-NP-induced cytotoxicity, as determined by the release of lactate dehydrogenase, was also reduced by memantine with EC50 values from 1.7 to 2.3 microM. Propidium iodide fluorescence and phase contrast microscopy confirmed memantine neuroprotection against the chronic toxin exposure. In addition, the protected tissue exhibited normal neuronal morphology in the major hippocampal subfields. These results indicate that antagonists of NMDA-type glutamate receptors are protective during the toxic outcome associated with mitochondrial dysfunction. They also provide further evidence of memantine's therapeutic potential against neurodegenerative diseases. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897723     DOI: 10.1002/hipo.20214

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  14 in total

1.  Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain.

Authors:  Gislaine Z Réus; Roberto B Stringari; Gislaine T Rezin; Daiane B Fraga; Juliana F Daufenbach; Giselli Scaini; Joana Benedet; Natália Rochi; Emílio L Streck; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2011-09-28       Impact factor: 3.575

Review 2.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 3.  The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer's disease.

Authors:  Carolyn C Rudy; Holly C Hunsberger; Daniel S Weitzner; Miranda N Reed
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

4.  Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat.

Authors:  G Akopian; C Crawford; G Petzinger; M W Jakowec; J P Walsh
Journal:  Neuroscience       Date:  2012-04-30       Impact factor: 3.590

5.  Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: possible nitric oxide mechanisms.

Authors:  Puneet Kumar; Anil Kumar
Journal:  Psychopharmacology (Berl)       Date:  2009-09-18       Impact factor: 4.530

6.  N-methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity.

Authors:  Payman Nasr; Timothy Carbery; James W Geddes
Journal:  Neurochem Res       Date:  2008-08-08       Impact factor: 3.996

7.  Neuroprotective effects of memantine in a mouse model of retinal degeneration induced by rotenone.

Authors:  Julio C Rojas; Jose A Saavedra; F Gonzalez-Lima
Journal:  Brain Res       Date:  2008-04-12       Impact factor: 3.252

8.  Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway.

Authors:  G Liot; B Bossy; S Lubitz; Y Kushnareva; N Sejbuk; E Bossy-Wetzel
Journal:  Cell Death Differ       Date:  2009-03-20       Impact factor: 15.828

9.  Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors.

Authors:  Do Young Kim; Johana Vallejo; Jong M Rho
Journal:  J Neurochem       Date:  2010-04-02       Impact factor: 5.372

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.